Abstract: A cloud service system manages a filter repository including filters for encoding and decoding media content (e.g. text, image, audio, video, etc.). The cloud service system may receive a request from a client device to provide a filter for installation on a node such as an endpoint device (e.g. pipeline node). The request includes information such as a type of bitstream to be processed by the requested filter. The request may further include other information such as hardware configuration and functionality attribute. The cloud service system may access the filter repository that stores the plurality of filters including encoder filters and decoder filters and may select a filter that is configured to process the type of bitstream identified in the request and provide the selected filter to the client device.

Abstract: A load control system may be commissioned using beacons. The load control system may include control devices that each include a beacon transmitting circuit configured to transmit a beacon that comprises an identifier associated with the control device. A network device, such as a mobile device, may discover a control device based on the beacon received from the control device. In response to discovery of the control device, the control device may be added to a temporary group of control devices for being collectively configured and/or controlled. Control devices may be discovered based on the signal strength at which the beacons are received. The control devices may provide feedback to a user in response to confirmation messages to indicate to a user that the lighting control device has been added to the temporary group. The control devices may stop providing the feedback after they are removed from the temporary group.

Abstract: An air intake and exhaust system for a marine engine having an intake manifold and an exhaust manifold includes an air compressor configured to compress ambient air into compressed air and a catalytic converter assembly configured to convert pollutants in an exhaust gas stream received from the exhaust manifold. The air compressor is configured to be fluidly coupled to the intake manifold of the engine for directing at least a first portion of the compressed air to the intake manifold of the engine. The air compressor is also selectively fluidly coupled to the catalytic converter assembly for selectively directing a second portion of the compressed air into the exhaust gas stream at a secondary air injection location at or upstream of the catalytic converter assembly.

Abstract: An eye mask for use to wake up and/or to go to sleep provides ease of cleaning or replacement without damaging electrical or optical components; different user selectable sunrise and sunset illumination modes respectively having blue-shifted and red-shifted spectra simulating natural sunrises and sunsets to assimilate the sleep/wake cycle to the natural rhythms of day and night; sunset and/or sunrise illumination modes that oscillate with fixed period or sequentially changing periods that correspond to brainwave frequencies that respectively facilitate going to sleep and/or waking and synergistically co-operate with corresponding sunset or sunrise light fields to help the user to fall into restful sleep or to awake refreshed and alert; and audio tone programming of illumination mode and treatment time and/or duration of therapy by a remote tone control generator.

Abstract: Biomedical devices for implantation with decreased pericapsular fibrotic overgrowth are disclosed. The device includes biocompatible materials and has specific characteristics that allow the device to elicit less of a fibrotic reaction after implantation than the same device lacking one or more of these characteristic that are present on the device. Biocompatible hydrogel capsules encapsulating mammalian cells having a diameter of greater than 1 mm, and optionally a cell free core, are disclosed which have reduced fibrotic overgrowth after implantation in a subject. Methods of treating a disease in a subject are also disclosed that involve administering a therapeutically effective amount of the disclosed encapsulated cells to the subject.

Abstract: Methods and constructs for engineering circular RNA are disclosed. In some embodiments, the methods and constructs comprise a vector for making circular RNA, the vector comprising the following elements operably connected to each other and arranged in the following sequence: a.) a 5? homology arm, b.) a 3? group I intron fragment containing a 3? splice site dinucleotide, c.) optionally, a 5? spacer sequence, d.) a protein coding or noncoding region, e.) optionally, a 3? spacer sequence, f) a 5? Group I intron fragment containing a 5? splice site dinucleotide, and g.) a 3? homology arm, the vector allowing production of a circular RNA that is translatable or biologically active inside eukaryotic cells. Methods for purifying the circular RNA produced by the vector and the use of nucleoside modifications in circular RNA produced by the vector are also disclosed.

Abstract: A load control system may be commissioned using beacons. The load control system may include control devices that each include a beacon transmitting circuit configured to transmit a beacon that comprises an identifier associated with the control device. A network device, such as a mobile device, may discover a control device based on the beacon received from the control device. In response to discovery of the control device, the control device may be added to a temporary group of control devices for being collectively configured and/or controlled. Control devices may be discovered based on the signal strength at which the beacons are received. The control devices may provide feedback to a user in response to confirmation messages to indicate to a user that the lighting control device has been added to the temporary group. The control devices may stop providing the feedback after they are removed from the temporary group.

Abstract: Disclosed herein are methods and devices for the inactivation of pathogens (e.g., bacteria, viruses, etc.) in ex vivo stored blood products, such as plasma and/or platelets, by means of directing visible light radiation from an illuminating device into blood product storage containers in order to achieve effective pathogen inactivation without the presence of an added photosensitising agent in the blood product. An exemplary apparatus includes a control unit that operates a light source that emits light in the wavelength region of about 380-500 nm which is directed onto blood product storage bags at sufficient intensity to penetrate the bag material and the opaque blood product therein in order to inactivate pathogens in the blood product but at dose levels that cause no significant detrimental effects on the blood product.

Abstract: Method and systems of determining when to replace an air data probe are provided. The method includes estimating air data probe temperatures based at least in part on available vehicle sensor data; tracking an amount of time an estimated temperature of the heating element is within at least one temperature range; and providing an air data probe replacement indication when a replacement threshold is met that is at least in part based on reaching a cumulative amount of time the heating element has an estimated temperature within the at least one temperature range.

Abstract: An eye mask for use to wake up and/or to go to sleep provides ease of cleaning or replacement without damaging electrical or optical components; different user selectable sunrise and sunset illumination modes respectively having blue-shifted and red-shifted spectra simulating natural sunrises and sunsets to assimilate the sleep/wake cycle to the natural rhythms of day and night; sunset and/or sunrise illumination modes that oscillate with fixed period or sequentially changing periods that correspond to brainwave frequencies that respectively facilitate going to sleep and/or waking and synergistically co-operate with corresponding sunset or sunrise light fields to help the user to fall into restful sleep or to awake refreshed and alert; and audio tone programming of illumination mode and treatment time and/or duration of therapy by a remote tone control generator.

Abstract: With the world's rapid advancement of technology, the demand and need for the materials that make up that technology has exploded. An important group of materials needed in this rapid advancement are the rare earth elements (REE) used in countless necessary applications. One source of rare earths found in the United States is bastnaesite, a rare earth bearing fluorocarbonate, mined at the Mountain Pass Mine in California. To increase production, it has been essential to optimize existing processes and create new ones to exploit current reserves. This research program was run to expand the understanding of the bastnaesite leaching system. A novel single stage hydrochloric leach system was created to optimize the rare earth extraction from bastnaesite. Typically, this process has utilized a two-stage leach system involving a high temperature hydrochloric acid leach followed by a caustic crack.

Abstract: A compression system trains a compression model for an encoder and decoder. In one embodiment, the compression model includes a machine-learned in-loop flow predictor that generates a flow prediction from previously reconstructed frames. The machine-learned flow predictor is coupled to receive a set of previously reconstructed frames and output a flow prediction for a target frame that is an estimation of the flow for the target frame. In particular, since the flow prediction can be generated by the decoder using the set of previously reconstructed frames, the encoder may transmit a flow delta that indicates a difference between the flow prediction and the actual flow for the target frame, instead of transmitting the flow itself. In this manner, the encoder can transmit a significantly smaller number of bits to the receiver, improving computational efficiency.

Abstract: The present disclosure relates to a thermoplastic film that includes a plurality of ribs and a plurality of web areas that separate and connect the ribs. The thermoplastic film further includes an encapsulated odor control component that includes an odor control active encapsulated within a plurality of encapsulants. The encapsulants can be configured to delay a release of the odor-control active until activated. Further, the encapsulated odor control component can be applied across the plurality of ribs and the plurality of web areas, which can be configured to cause the encapsulants to activate in phases.

Abstract: A compression system trains a machine-learned compression model that includes components for an encoder and decoder. In one embodiment, the compression model is trained to receive parameter information on how a target frame should be encoded with respect to one or more encoding parameters, and encodes the target frame according to the respective values of the encoding parameters for the target frame. In particular, the encoder of the compression model includes at least an encoding system configured to encode a target frame and generate compressed code that can be transmitted by, for example, a sender system to a receiver system. The decoder of the compression model includes a decoding system trained in conjunction with the encoding system. The decoding system is configured to receive the compressed code for the target frame and reconstruct the target frame for the receiver system.

Abstract: The present disclosure relates to a thermoplastic film that includes dual fragrance odor control. For example, the thermoplastic can film include a first fragrance component, such as a neat oil applied directly thereon. The thermoplastic film can also include an encapsulated fragrance component applied thereon. The encapsulated fragrance component can include a fragrance encapsulated within a plurality of encapsulants and can be configured to delay a release of the fragrance, such as until there is a physical interaction applied to the thermoplastic film.

Abstract: Circular RNA and transfer vehicles, along with related compositions and methods are described herein. In some embodiments, the inventive circular RNA comprises group I intron fragments, spacers, an IRES, duplex forming regions, and an expression sequence. In some embodiments, the expression sequence encodes a chimeric antigen receptor (CAR). In some embodiments, circular RNA of the invention has improved expression, functional stability, immunogenicity, ease of manufacturing, and/or half-life when compared to linear RNA. In some embodiments, inventive methods and constructs result in improved circularization efficiency, splicing efficiency, and/or purity when compared to existing RNA circularization approaches.

Abstract: Methods and constructs for engineering circular RNA are disclosed. In some embodiments, the methods and constructs comprise a vector for making circular RNA, the vector comprising the following elements operably connected to each other and arranged in the following sequence: a.) a 5? homology arm, b.) a 3? group I intron fragment containing a 3? splice site dinucleotide, c.) optionally, a 5? spacer sequence, d.) a protein coding or noncoding region, e.) optionally, a 3? spacer sequence, f) a 5? Group I intron fragment containing a 5? splice site dinucleotide, and g.) a 3? homology arm, the vector allowing production of a circular RNA that is translatable or biologically active inside eukaryotic cells. Methods for purifying the circular RNA produced by the vector and the use of nucleoside modifications in circular RNA produced by the vector are also disclosed.

Abstract: Methods and constructs for engineering circular RNA are disclosed. In some embodiments, the methods and constructs comprise a vector for making circular RNA, the vector comprising the following elements operably connected to each other and arranged in the following sequence: a.) a 5? homology arm, b.) a 3? group I intron fragment containing a 3? splice site dinucleotide, c.) optionally, a 5? spacer sequence, d.) a protein coding or noncoding region, e.) optionally, a 3? spacer sequence, f.) a 5? Group I intron fragment containing a 5? splice site dinucleotide, and g.) a 3? homology arm, the vector allowing production of a circular RNA that is translatable or biologically active inside eukaryotic cells. Methods for purifying the circular RNA produced by the vector and the use of nucleoside modifications in circular RNA produced by the vector are also disclosed.

Abstract: A pill-dispensing system includes a base including a first processor and a storage, a container for pills carried by the base, and a dispenser mechanism. A data store includes an authorization code and instructions. A second processor is coupled to the data store, is in communication with the first processor, and is programmed to receive from the first processor a code associated with the container, compare the code to the authorization code, and retrieve and serve the instructions to the first processor upon the code matching the authorization code. The first processor is programmed, upon receiving the instructions from the second processor, to download to the storage the instructions that when executed by the first processor cause the first processor to effectuate a dispensing of pills from the container by the dispenser mechanism.

Abstract: An apparatus for dissipating thermal energy including a baseplate including a first body having a first groove and a second groove intersecting one another, the first groove and the second groove formed in and only accessible from a first side of the baseplate. The apparatus including a first heat pipe and a second heat pipe arranged and disposed to provide both an overlapping arrangement and a nonoverlapping arrangement within the first groove and the second groove of the baseplate.